Monocl develops software to connect all stakeholders in the life sciences industry, allowing professionals to target and engage opinion leaders, physicians and scientists. The platform is used by large industry players including Pfizer, Novartis, Takeda and AstraZeneca. GP Bullhound's Joakim Dal said Monocl can translate processes that would take two to three weeks into minutes while providing up-to-date access to data. The company will use the €3 million investment from GP Bullhound to expand across the Atlantic, including establishing a US headquarters in Boston, Massachusetts. Funds will also support growth of sales, marketing, customer service and product development teams in targeted markets. CEO and co-founder Björn Carlsson said the round was unplanned but well-timed with his planned relocation to the US.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2019